| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Minireview |
From the Division of Urology, Department of Surgery, University of Tennessee Graduate School of Medicine, Knoxville, Tennessee.
| Correspondence to: Dr Edward D. Kim, Department of Urology and Urologic Surgery, University of Tennessee Graduate School of Medicine, 1928 Alcoa Hwy, Suite 222, Knoxville, TN 37920 (e-mail: ekim{at}mc.utmck.edu). |
Penile rehabilitation has been an area of intense study and debate over the
last decade. Interest in this topic was stimulated by the observation that
erectile dysfunction remained a significant problem after radical
prostatectomy despite meticulous nerve-sparing technique. Smooth muscle
alterations and fibrotic changes in the penis were identified as the
underlying causes of penile atrophy, veno-occlusive dysfunction, and
Peyronie's-like changes that were observed after surgery. Initial observations
that intracavernous injection therapies used on a regular basis
postoperatively resulted in improvements in the return of spontaneous erectile
function led to the development of penile rehabilitation protocols. Chronic
dosing of oral type V phosphodiesterase inhibitors is now commonly used by
urologists after radical prostatectomy despite a lack of convincing evidence
from randomized, placebo-controlled clinical trials. Use of local therapies to
heal the penis may have applications beyond the postprostatectomy patient.
This article reviews the current evidence behind penile rehabilitation
therapy.
Key words: Penile rehabilitation, radical prostatectomy
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |